Home›Search›Therapeutic Advances in Respiratory Disease

Therapeutic Advances in Respiratory Disease

SAGE Publications Ltd · United Kingdom · Est. 1984

ISSN1753-4658eISSN1753-4666

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.009

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.934

Total Worksi

975

Total Citationsi

21,021

2yr Mean Citednessi

2.79

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Respiratory System; Pharmacology (medical); Pulmonary and Respiratory Medicine.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1984

FrequencyBimonthly

StatusActive (last: 2026)

Total Publications975

Publisher OrgSAGE Publishing

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewOpen

Review Time~15 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Scholars PortalCLOCKSSLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

SAGE Publications Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1753-4658 / 1753-4666

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Open

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Scholars Portal, CLOCKSS, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.7k

2019

2.6k

2020

1.1k

2021

1.2k

2022

773

2023

467

2024

105

322

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology (medical)Q1

Pulmonary and Respiratory MedicineQ1

Subject Classification

Web of Science Categories

Respiratory System

Scopus Categories

Pharmacology (medical)Pulmonary and Respiratory Medicine

Research Topics (OpenAlex)

Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesRespiratory Support and MechanismsRespiratory and Cough-Related ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInhalation and Respiratory Drug DeliveryCystic Fibrosis Research AdvancesPulmonary Hypertension Research and TreatmentsLung Cancer Diagnosis and TreatmentTracheal and airway disorders

Frequently asked questions about Therapeutic Advances in Respiratory Disease

Is Therapeutic Advances in Respiratory Disease a predatory journal?

PubScope has no integrity flags on record for Therapeutic Advances in Respiratory Disease: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Advances in Respiratory Disease?

Therapeutic Advances in Respiratory Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.79.

Is Therapeutic Advances in Respiratory Disease indexed in Scopus and Web of Science?

Therapeutic Advances in Respiratory Disease is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Therapeutic Advances in Respiratory Disease?